These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 26722849)

  • 21. Advanced MRI may complement histological diagnosis of lower grade gliomas and help in predicting survival.
    Cuccarini V; Erbetta A; Farinotti M; Cuppini L; Ghielmetti F; Pollo B; Di Meco F; Grisoli M; Filippini G; Finocchiaro G; Bruzzone MG; Eoli M
    J Neurooncol; 2016 Jan; 126(2):279-88. PubMed ID: 26468137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Single agent carboplatin for pediatric low-grade glioma: A retrospective analysis shows equivalent efficacy to multiagent chemotherapy.
    Dodgshun AJ; Maixner WJ; Heath JA; Sullivan MJ; Hansford JR
    Int J Cancer; 2016 Jan; 138(2):481-8. PubMed ID: 26235348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute progression of untreated incidental WHO Grade II glioma to glioblastoma in an asymptomatic patient.
    Cochereau J; Herbet G; Rigau V; Duffau H
    J Neurosurg; 2016 Jan; 124(1):141-5. PubMed ID: 26162036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Different aetiology of familial low-grade and high-grade glioma? A nationwide cohort study of familial glioma.
    Malmer B; Henriksson R; Grönberg H
    Neuroepidemiology; 2002; 21(6):279-86. PubMed ID: 12411730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and treatment factors determining long-term outcomes for adult survivors of childhood low-grade glioma: A population-based study.
    Krishnatry R; Zhukova N; Guerreiro Stucklin AS; Pole JD; Mistry M; Fried I; Ramaswamy V; Bartels U; Huang A; Laperriere N; Dirks P; Nathan PC; Greenberg M; Malkin D; Hawkins C; Bandopadhayay P; Kieran MW; Manley PE; Bouffet E; Tabori U
    Cancer; 2016 Apr; 122(8):1261-9. PubMed ID: 26970559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparative analysis of clinicopathological features and survival among early adolescents/young adults and children with low-grade glioma: a report from the Children's Oncology Group.
    Margol AS; Yeo KK; Xia C; Onar A; Robison NJ; Freyer DR; Dhall G
    J Neurooncol; 2018 Dec; 140(3):575-582. PubMed ID: 30173409
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low-grade gliomas of the cerebral hemispheres in children: an analysis of 71 cases.
    Pollack IF; Claassen D; al-Shboul Q; Janosky JE; Deutsch M
    J Neurosurg; 1995 Apr; 82(4):536-47. PubMed ID: 7897512
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term outcome of centrally located low-grade glioma in children.
    Terashima K; Chow K; Jones J; Ahern C; Jo E; Ellezam B; Paulino AC; Okcu MF; Su J; Adesina A; Mahajan A; Dauser R; Whitehead W; Lau C; Chintagumpala M
    Cancer; 2013 Jul; 119(14):2630-8. PubMed ID: 23625612
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subventricular zone predicts high velocity of tumor expansion and poor clinical outcome in patients with low grade astrocytoma.
    Wen B; Fu F; Hu L; Cai Q; Xie J
    Clin Neurol Neurosurg; 2018 May; 168():12-17. PubMed ID: 29500965
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Value of diffusion tensor imaging in differentiating high-grade from low-grade gliomas.
    Piyapittayanan S; Chawalparit O; Tritakarn SO; Witthiwej T; Sangruchi T; Nunta-Aree S; Sathornsumetee S; Itthimethin P; Komoltri C
    J Med Assoc Thai; 2013 Jun; 96(6):716-21. PubMed ID: 23951830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Velocity of tumor spontaneous expansion predicts long-term outcomes for diffuse low-grade gliomas.
    Pallud J; Blonski M; Mandonnet E; Audureau E; Fontaine D; Sanai N; Bauchet L; Peruzzi P; Frénay M; Colin P; Guillevin R; Bernier V; Baron MH; Guyotat J; Duffau H; Taillandier L; Capelle L
    Neuro Oncol; 2013 May; 15(5):595-606. PubMed ID: 23393207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progressive Low-Grade Glioma: Assessment of Prognostic Importance of Histologic Reassessment and MRI Findings.
    Narang AK; Chaichana KL; Weingart JD; Redmond KJ; Lim M; Olivi A; Quinones-Hinojosa A; Kleinberg LR
    World Neurosurg; 2017 Mar; 99():751-757. PubMed ID: 27108796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glioma Grade Discrimination with MR Diffusion Kurtosis Imaging: A Meta-Analysis of Diagnostic Accuracy.
    Falk Delgado A; Nilsson M; van Westen D; Falk Delgado A
    Radiology; 2018 Apr; 287(1):119-127. PubMed ID: 29206593
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Depression and survival of glioma patients: A systematic review and meta-analysis.
    Shi C; Lamba N; Zheng LJ; Cote D; Regestein QR; Liu CM; Tran Q; Routh S; Smith TR; Mekary RA; Broekman MLD
    Clin Neurol Neurosurg; 2018 Sep; 172():8-19. PubMed ID: 29957299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic, treatment, and demographic factors influencing survival in a population-based study of adult glioma patients in the San Francisco Bay Area.
    Wrensch M; Rice T; Miike R; McMillan A; Lamborn KR; Aldape K; Prados MD
    Neuro Oncol; 2006 Jan; 8(1):12-26. PubMed ID: 16443944
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic factors and survival patterns in pediatric low-grade gliomas over 4 decades.
    Youland RS; Khwaja SS; Schomas DA; Keating GF; Wetjen NM; Laack NN
    J Pediatr Hematol Oncol; 2013 Apr; 35(3):197-205. PubMed ID: 22983418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Age and surgical outcome of low-grade glioma in Sweden.
    Corell A; Carstam L; Smits A; Henriksson R; Jakola AS
    Acta Neurol Scand; 2018 Oct; 138(4):359-368. PubMed ID: 29900547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Involvement of the neural stem cell compartment by pediatric and adult gliomas: a retrospective review of 377 cases.
    Marsh JC; Goldman S; Ziel E; Bregman C; Diaz A; Byrne R; Fangusaro J
    J Neurooncol; 2015 Mar; 122(1):105-10. PubMed ID: 25502962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective clinical trials of intracranial low-grade glioma in adults and children.
    Shaw EG; Wisoff JH
    Neuro Oncol; 2003 Jul; 5(3):153-60. PubMed ID: 12816721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase II pilot study of single-agent etirinotecan pegol (NKTR-102) in bevacizumab-resistant high grade glioma.
    Nagpal S; Recht CK; Bertrand S; Thomas RP; Ajlan A; Pena J; Gershon M; Coffey G; Kunz PL; Li G; Recht LD
    J Neurooncol; 2015 Jun; 123(2):277-82. PubMed ID: 25935109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.